[PDF] Top 20 Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma

... laryngeal carcinoma, and hypopharyngeal ...on immunotherapy which is considered to be an alternative treatment approach for cancers in general, while several studies are underway testing the effectiveness ... See full document

... Recent advances in our understanding of the molecular pathogenesis of HNSCC were provided by whole-exome sequencing ...proliferation, squamous epithelial differentiation, cell survival, and ... See full document

... advanced head and neck squamous carcinoma cell (HNSCC) is dismal (<25%), and these statistics have remained largely unchanged for decades despite advances in surgical ... See full document

... with squamous and intermediate differentiation are commonly acetylated, but hypoacetylated tumor cells are also present within the tumor ...the cell [61, ...stem cell-associated ...certain ... See full document

... predictive of benefit from immunotherapy with respect to chemotherapy [90]. On the other hand, Herbst and colleagues observed that the responses to the anti-PD-L1 MPDL3280A were associated with high expression of ... See full document

... recurrent squamous-cell carcinoma of the head and neck (including metastatic disease) of the oral cavity, pharynx, or larynx that was not ame- nable to curative treatment; tumor ... See full document

... Unchecked cell growth is a hallmark of ...keeps cell growth in ...in head and neck squamous cell carcinoma (HNSCC) remains ...the head and neck epithelium of ... See full document

... cancer, head and neck squamous cell carcinoma, esophageal squamous cell carcinoma, oral squamous cell carcinoma, gallbladder cancer, pancreatic ... See full document

... grammed cell death 4(PDCD4) in HNSCC, [81] and esophageal carcinoma, [117] it stimulates cell invasion and promotes metastasis in breast cancer by targeting both PDCD4, and tropomyosin 1 (TPM1), a ... See full document

... Although Hematoxylin&Eosin staining is the routine staining for histopathological examination, only a few studies about TILs with this staining had been done. The previous studies for TILs with Hematoxylin&Eosin ... See full document

... There is a high relationship between HPV infection and cervical carcinoma. Though the epidemiological, molecular and clinical findings show that in some cases who have not used tobacco and/or alcohol, high risk ... See full document

... & Neck 1 (LHN1) trial, afatinib signi fi cantly improved progression-free survival (PFS) and patient-reported outcomes versus methotrex- ate in R/M HNSCC patients progressing on/after platinum- based therapy ... See full document

... In our study, we detected the amplification of hTERC by FISH in all cases of invasive carcinoma of larynx. This result indicates demonstrated that amplification of the hTERC gene is one of the most frequent ... See full document

... basaloid squamous cell carcinoma (EBSCC) is a rare histological form of esophageal cancer and reportedly accounts for ...Basaloid squamous cell carcinoma (BSCC) is a high-grade ... See full document

... cancer cell line FaDu were ...cancer cell line KB, the IC50 values were lower than those in cancer cell line ...cancer cell line KB was ...cancer cell line ...cancer cell line ... See full document

... The ability of the EGFR-specific peptides (KLF, YLN) to stabilize the HLA-A2 complex on the surface of TAP- deficient T2 cells in relation to the FLU peptide is shown in Figure 1. In the T2-assay, stabilisation of the ... See full document

... in head and neck squamous cell carcinoma (HNSCC); however, whether it plays a role in determining clinical outcome remains still ...reduced cell proliferation and enhanced ... See full document

... firmed that, in a mice model, distinct subsets of Treg cells have similar variations in function as in humans. Furthermore, CCR4 expression on the 3 subsets of mouse Tregs was investigated, finding that CCR4 was ... See full document

... cancer immunotherapy is how to evaluate therapeutic response given that the kinetics of patient response to immuno- therapy may be different than with cytotoxic chemother- ...receiving checkpoint inhibitors ... See full document

... cell carcinoma, OPSCC, represents 10% - 15% of all head and neck tumors and has an annual incidence of 10 per million per year in the UK ...site carcinoma in the oropharynx is tonsil or ... See full document